Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

FDA plans to release more drug rejection letters as controversial policy resumes - Fierce Biotech

news.google.com · 22 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA panel endorses broader use of certain peptides - BioPharma Dive

news.google.com · 22 Aug 2026

Google News – FDA (biotech/pharma) External News

New FDA product-specific guidances on generic drug development - The Pharma Letter

news.google.com · 22 Aug 2026

Google News – FDA (biotech/pharma) External News

Earnings call transcript: Ascelia Pharma narrows Q2 loss as FDA setback weighs on shares - Investing.com

news.google.com · 22 Aug 2026

Google News – FDA (biotech/pharma) External News

Aurobindo Pharma Says US FDA Conducted Inspection At Auropeptides From August 17 To August 21 - TradingView

news.google.com · 22 Aug 2026

Google News – FDA (biotech/pharma) External News

Ascelia Pharma Q2 2026 slides: FDA setback delays Orviglance path - Investing.com

news.google.com · 22 Aug 2026

Google News – Medical Devices External News

5 things to know in life sciences: Week of Aug. 17, 2026 - The Real Economy Blog

news.google.com · 22 Aug 2026

Google News – Medical Devices External News

HHS to end emergency authorization for COVID-19 drugs, medical devices - American Hospital Association

news.google.com · 22 Aug 2026

Google News – Medical Devices External News

Poor-quality medical devices being sold in India, stronger finished-product testing needed, says Pharma Secretary - BusinessLine

news.google.com · 22 Aug 2026

Google News – Clinical Trials External News

Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift - drugdiscoverytrends.com

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Napo Pharmaceuticals Updates Mytesi Prescribing Information for HIV/AIDS Patients on Antiretroviral Therapy - geneonline.com

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

B. Metzler seel. Sohn & Co. AG Acquires Shares of 231,381 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Wealthfront Advisers LLC Invests $4.37 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Renova Pharmaceuticals Updates Prescribing Information for Ascorbic Acid Injection - geneonline.com

news.google.com · 22 Aug 2026

Google News – Pharmaceuticals External News

Silvant Capital Management LLC Takes $5.46 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat

news.google.com · 22 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

BBC Inside Science

Doctors said I was too young to have endometriosis at 13 - I had to take morphine to cope

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA plans to release more drug rejection letters as controversial policy resumes - Fierce Biotech

FDA panel endorses broader use of certain peptides - BioPharma Dive

New FDA product-specific guidances on generic drug development - The Pharma Letter

Earnings call transcript: Ascelia Pharma narrows Q2 loss as FDA setback weighs on shares - Investing.com

Aurobindo Pharma Says US FDA Conducted Inspection At Auropeptides From August 17 To August 21 - TradingView

Ascelia Pharma Q2 2026 slides: FDA setback delays Orviglance path - Investing.com

5 things to know in life sciences: Week of Aug. 17, 2026 - The Real Economy Blog

HHS to end emergency authorization for COVID-19 drugs, medical devices - American Hospital Association

Poor-quality medical devices being sold in India, stronger finished-product testing needed, says Pharma Secretary - BusinessLine

Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift - drugdiscoverytrends.com

Napo Pharmaceuticals Updates Mytesi Prescribing Information for HIV/AIDS Patients on Antiretroviral Therapy - geneonline.com

B. Metzler seel. Sohn & Co. AG Acquires Shares of 231,381 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat

Wealthfront Advisers LLC Invests $4.37 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Renova Pharmaceuticals Updates Prescribing Information for Ascorbic Acid Injection - geneonline.com

Silvant Capital Management LLC Takes $5.46 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat